Easier treatment for multiple myeloma: can fewer drug doses work just as well?
NCT ID NCT06348147
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 30 times
Summary
This study tests a modified, less intense drug schedule for people newly diagnosed with multiple myeloma who are eligible for a stem cell transplant. The standard treatment requires two drug doses per week, which can be hard to tolerate. This study gives the drugs once a week to see if it still effectively clears cancer cells from the bone marrow while being easier on patients. About 39 adults will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, 27516, United States
Conditions
Explore the condition pages connected to this study.